Translational Utility of Liquid Biopsies in Thyroid Cancer Management

Cancers

Ayanthi A. Wijewardene¹  Matti L. Gild¹  Roderick J. Clifton-Bligh¹  Martyn Bullock¹  Marthe Chehade² 

[1] Department of Endocrinology, Royal North Shore Hospital, Sydney, NSW 2052, Australia;Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2052, Australia;

关键词: liquid biopsy;    circulating tumor DNA (ctDNA);    cell free DNA (cfDNA);    microRNA (miRNA);    thyroid cancer;   

DOI  :  10.3390/cancers13143443

来源: DOAJ

【 摘 要 】

Liquid biopsies are a novel technique to assess for either circulating tumor cells (CTC) or circulating tumor DNA (ctDNA and microRNA (miRNA)) in peripheral blood samples of cancer patients. The diagnostic role of liquid biopsy in oncology has expanded in recent years, particularly in lung, colorectal and breast cancer. In thyroid cancer, the role of liquid biopsy in either diagnosis or prognosis is beginning to translate from the lab to the clinic. In this review, we describe the evolution of liquid biopsies in detecting CTC, ctDNA and miRNA in thyroid cancer patients, together with its limitations and future directions in clinical practice.

【 授权许可】

Unknown